NHBAF logo

Nichiban Co., Ltd. (NHBAF)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Nichiban Co., Ltd. (NHBAF) with AI Score 53/100 (Hold). Nichiban Co. , Ltd. manufactures and sells medical products and tapes across Asia and Europe. Market cap: 0, Sector: Industrials.

Last analyzed: Mar 18, 2026
Nichiban Co., Ltd. manufactures and sells medical products and tapes across Asia and Europe. The company's diverse product portfolio includes medical, OTC, taping, stationery, and industrial tapes.
53/100 AI Score

Nichiban Co., Ltd. (NHBAF) Industrial Operations Profile

CEOToshiaki Takatsu
Employees1270
HeadquartersTokyo, JP
IPO Year2020

Nichiban Co., Ltd., founded in 1918, is a Japanese manufacturer and distributor of medical products and various tape solutions, including surgical, OTC, stationery, and industrial tapes, with a presence in Asia and Europe and a market capitalization of $0.26 billion.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 18, 2026

Investment Thesis

Nichiban Co., Ltd. presents a stable investment profile within the industrials sector, characterized by its diversified product range and established presence in Asia and Europe. The company's modest profit margin of 3.1% and gross margin of 29.5% suggest opportunities for operational improvements. A dividend yield of 1.83% provides a steady income stream for investors. The low beta of 0.20 indicates lower volatility compared to the broader market. Growth catalysts include expanding into new geographic markets and developing innovative tape solutions. Potential risks include fluctuating raw material costs and increasing competition from global tape manufacturers. The company's P/E ratio of 25.02 reflects its current valuation relative to earnings.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.26 billion, reflecting the company's current market value.
  • P/E ratio of 25.02, indicating the price investors are willing to pay for each dollar of earnings.
  • Profit margin of 3.1%, showcasing the company's profitability after all expenses.
  • Gross margin of 29.5%, representing the percentage of revenue exceeding the cost of goods sold.
  • Dividend yield of 1.83%, providing a return to investors through dividend payments.

Competitors & Peers

Strengths

  • Diversified product portfolio.
  • Established presence in Asia and Europe.
  • Strong brand reputation in Japan.
  • Low beta indicating lower volatility.

Weaknesses

  • Relatively low profit margin.
  • Limited geographic presence outside Asia and Europe.
  • Dependence on raw material costs.
  • Modest market capitalization.

Catalysts

  • Upcoming: Potential expansion into new geographic markets in Southeast Asia by Q4 2026.
  • Ongoing: Continued investment in research and development for innovative tape solutions.
  • Ongoing: Strengthening of e-commerce and digital marketing efforts to drive online sales.

Risks

  • Potential: Fluctuations in raw material costs affecting profitability.
  • Potential: Increasing competition from global tape manufacturers.
  • Ongoing: Economic downturns affecting industrial demand.
  • Potential: Regulatory changes in healthcare and environmental standards.

Growth Opportunities

  • Expansion into Emerging Markets: Nichiban can pursue growth by expanding its presence in emerging markets across Asia and Latin America. These regions exhibit increasing demand for medical and industrial tapes, driven by growing healthcare sectors and industrialization. A targeted market entry strategy, focusing on localized product offerings and distribution networks, could significantly boost revenue. The global market for adhesive tapes in emerging economies is projected to grow at a CAGR of 5-7% over the next five years.
  • Development of Innovative Tape Solutions: Investing in research and development to create innovative tape solutions for specialized applications can drive growth. This includes developing advanced medical tapes with enhanced adhesive properties, eco-friendly industrial tapes, and smart tapes with sensor technology. Collaborating with research institutions and industry partners can accelerate the innovation process. The market for specialized tapes is expanding, with applications in electronics, aerospace, and renewable energy sectors.
  • Strategic Acquisitions and Partnerships: Nichiban can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. Acquiring smaller tape manufacturers with complementary product lines or entering into partnerships with distributors in new markets can accelerate growth. Identifying synergistic opportunities and conducting thorough due diligence are crucial for successful acquisitions and partnerships. The M&A activity in the tape and adhesive industry remains robust, with numerous opportunities for consolidation.
  • Enhancing E-commerce and Digital Marketing: Strengthening its e-commerce presence and digital marketing efforts can help Nichiban reach a broader customer base and drive online sales. Investing in a user-friendly online platform, optimizing search engine visibility, and leveraging social media marketing can enhance brand awareness and generate leads. The e-commerce channel for tapes and adhesive products is experiencing rapid growth, driven by convenience and accessibility.
  • Focus on Sustainable and Eco-Friendly Products: Developing and promoting sustainable and eco-friendly tape products can appeal to environmentally conscious customers and gain a competitive advantage. This includes using bio-based materials, reducing waste in manufacturing processes, and offering recyclable or biodegradable tape options. The demand for sustainable products is growing across various industries, driven by consumer preferences and regulatory requirements.

Opportunities

  • Expansion into emerging markets.
  • Development of innovative tape solutions.
  • Strategic acquisitions and partnerships.
  • Enhancing e-commerce and digital marketing.

Threats

  • Increasing competition from global tape manufacturers.
  • Fluctuations in raw material costs.
  • Economic downturns affecting industrial demand.
  • Regulatory changes in healthcare and environmental standards.

Competitive Advantages

  • Established brand reputation in the Japanese market.
  • Diversified product portfolio across medical, OTC, and industrial segments.
  • Distribution network in Asia and Europe.
  • Focus on specialized tape solutions for niche applications.

About NHBAF

Nichiban Co., Ltd., established in 1918 and headquartered in Tokyo, Japan, has evolved into a diversified manufacturer and distributor of medical products and tape solutions. Initially focused on adhesive tapes, the company expanded its product lines to include medical products, OTC offerings, stationery, and specialized industrial tapes. Nichiban's medical products range from surgical tapes and first-aid bandages to hemostatic bandages, catering to healthcare professionals and consumers. Their OTC products include anti-inflammatory patches and foot care solutions. The company's taping tapes cover cotton, elastic, and kinesiology applications, while their stationery products include cellulose and double-sided tapes. Nichiban also provides industrial tapes for packaging, agriculture, and automotive applications. With a presence in Asia and Europe, Nichiban serves a broad customer base across various sectors, maintaining a competitive position through its diversified product portfolio and established brand reputation.

What They Do

  • Manufactures and sells surgical tapes for medical applications.
  • Produces first-aid bandages and hemostatic bandages for wound care.
  • Offers anti-inflammatory patches and foot care products for OTC markets.
  • Provides cotton, elastic, and kinesiology taping tapes for sports and rehabilitation.
  • Manufactures cellulose and double-sided tapes for stationery purposes.
  • Supplies industrial tapes for packaging, agriculture, and automotive applications.
  • Offers specialized tapes for various industrial and commercial uses.

Business Model

  • Manufacturing and distribution of medical products and tapes.
  • Sales through direct channels, distributors, and retailers.
  • Revenue generation from a diversified product portfolio.
  • Focus on serving both consumer and industrial markets.

Industry Context

Nichiban Co., Ltd. operates within the business equipment and supplies industry, which is characterized by steady growth and demand for specialized products. The global adhesive tapes market is projected to reach billions of dollars by 2026, driven by increasing applications in packaging, healthcare, and automotive sectors. Competition includes companies like ALFNF (Alfen N.V.), DMCHY (DIC Corporation), and MBRFF (Nitto Denko Corporation), which offer similar products. Nichiban's diversified product portfolio and established presence in Asia and Europe position it to capture a share of this growing market.

Key Customers

  • Healthcare professionals and hospitals.
  • Retail consumers seeking first-aid and OTC products.
  • Athletes and sports medicine professionals.
  • Businesses in packaging, agriculture, and automotive industries.
AI Confidence: 72% Updated: Mar 18, 2026

Financials

Chart & Info

Nichiban Co., Ltd. (NHBAF) stock price: Price data unavailable

Latest News

No recent news available for NHBAF.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NHBAF.

Price Targets

Wall Street price target analysis for NHBAF.

MoonshotScore

53/100

What does this score mean?

The MoonshotScore rates NHBAF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Toshiaki Takatsu

CEO

Toshiaki Takatsu serves as the CEO of Nichiban Co., Ltd., overseeing the company's operations and strategic direction. His background includes extensive experience in the manufacturing and distribution of medical products and tape solutions. Prior to his role as CEO, Takatsu held various leadership positions within Nichiban, contributing to the company's growth and expansion. He is responsible for managing a workforce of 1270 employees and driving innovation across the company's product lines.

Track Record: Under Toshiaki Takatsu's leadership, Nichiban Co., Ltd. has focused on expanding its presence in key markets and developing innovative tape solutions. Key achievements include strengthening the company's e-commerce presence and driving growth in the medical products segment. Takatsu has also emphasized sustainability initiatives, focusing on developing eco-friendly tape options. His strategic decisions have contributed to maintaining Nichiban's competitive position in the industry.

NHBAF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Nichiban Co., Ltd. may not meet the minimum financial or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as exchange-listed companies. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity compared to stocks listed on major exchanges like the NYSE or NASDAQ.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity for NHBAF on the OTC market is likely limited, potentially leading to wider bid-ask spreads and difficulty in executing large trades without significantly impacting the price. Investors should be prepared for potentially lower trading volumes compared to exchange-listed stocks. Due diligence is crucial to assess the actual trading activity and potential challenges in buying or selling shares.
OTC Risk Factors:
  • Limited financial disclosure requirements.
  • Potential for lower trading volume and liquidity.
  • Wider bid-ask spreads.
  • Higher price volatility.
  • Risk of fraud or manipulation.
Due Diligence Checklist:
  • Verify the company's registration and legal status.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Check for any regulatory actions or legal issues.
  • Monitor trading volume and price activity.
  • Consult with a financial advisor.
Legitimacy Signals:
  • Established operating history since 1918.
  • Diversified product portfolio across multiple segments.
  • Presence in Asia and Europe.
  • Management team with industry experience.
  • Dividend payments to shareholders.

What Investors Ask About Nichiban Co., Ltd. (NHBAF)

What does Nichiban Co., Ltd. do?

Nichiban Co., Ltd. is a manufacturer and distributor of medical products and tape solutions. The company's product portfolio includes surgical tapes, first-aid bandages, anti-inflammatory patches, and various industrial and stationery tapes. Nichiban serves a diverse customer base across healthcare, retail, and industrial sectors, with a presence in Asia and Europe. The company's business model focuses on manufacturing quality products and distributing them through direct channels, distributors, and retailers.

What do analysts say about NHBAF stock?

As of March 18, 2026, there is no readily available analyst coverage for NHBAF stock due to its OTC listing. Investors should conduct their own due diligence and consider the company's financial performance, growth opportunities, and risk factors. Key valuation metrics include the P/E ratio of 25.02 and dividend yield of 1.83%. Growth considerations include expanding into new markets and developing innovative products. The company's modest profit margin of 3.1% warrants monitoring for potential improvements.

What are the main risks for NHBAF?

The main risks for Nichiban Co., Ltd. include fluctuations in raw material costs, increasing competition from global tape manufacturers, economic downturns affecting industrial demand, and regulatory changes in healthcare and environmental standards. As an OTC-listed company, NHBAF also faces risks related to limited financial disclosure, lower trading volume, and potential price volatility. Investors should carefully assess these risks before investing in NHBAF stock.

What are the key factors to evaluate for NHBAF?

Nichiban Co., Ltd. (NHBAF) currently holds an AI score of 53/100, indicating moderate score. Key strength: Diversified product portfolio.. Primary risk to monitor: Potential: Fluctuations in raw material costs affecting profitability.. This is not financial advice.

How frequently does NHBAF data refresh on this page?

NHBAF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven NHBAF's recent stock price performance?

Recent price movement in Nichiban Co., Ltd. (NHBAF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified product portfolio.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider NHBAF overvalued or undervalued right now?

Determining whether Nichiban Co., Ltd. (NHBAF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying NHBAF?

Before investing in Nichiban Co., Ltd. (NHBAF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • OTC market data may be limited.
  • AI analysis is pending for NHBAF.
Data Sources

Popular Stocks